Gene table



Gene symbol and protein
Gene Location
All allelic disease phenotypes - locus/disease symbols

MAG
myelin associated glycoprotein



19q13.12
* Spastic paraplegia 75, autosomal recessive - SPG75 (15.58)

MARS
methionyl-tRNA synthetase



12q13.3
* Charcot-Marie-Tooth 2 - (14.64)

MARS2
methionyl-tRNA synthetase 2, mitochondrial(M)



2q33-34
* autosomal recessive spastic ataxia with leukoencephalopathy - ARSAL (15.69)

MATR3
Matrin 3



5q31
* Vocal cord and pharyngeal distal myopathy - VCPDM (4.5, 12.58)
* Familial amyotrophic lateral sclerosis - ALS21 (4.5, 12.58)

MED25
Mediator complex subunit 25



19q13
* Charcot-Marie-Tooth disease, type 2B2 - CMT2B2 (14.69)

MEGF10
Multiple EGF-like-domains 10



5q23.2
* Recessive congenital myopathy with minicores - (3.27, 3.28)
* Early onset myopathy, areflexia, respiratory distress and dysphagia - EMARDD (3.27, 3.28)

MFN2
Mitofusin 2(M)



1p36.22
* Hereditary motor and sensory neuropathy 2A - CMT2A (14.41)

MME
membrane metallo-endopeptidase



3q25.2
* Charcot-Marie-Tooth neuropathy Type 2T - CMT2T (13.39, 14.58)
* Spinocerebellar Ataxia, type 43 - SCA43 (13.39, 14.58)

MORC2
MORC family CW-type zinc finger 2



2q12.2
* Charcot-Marie-Tooth neuropathy Type 2Z - CMT2Z (14.62)

MPZ
Myelin protein zero



1q22
* Charcot-Marie-Tooth disease, type 2I - CMT2I (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)
* Charcot-Marie-Tooth disease, type 2J - CMT2J (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)
* Charcot-Marie-Tooth disease, type 1B - CMT1B (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)
* Neuropathy, congenital hypomyelinating - CMT4E (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)
* Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)
* Dejerine-Sottas syndrome - DSSA (14.2, 14.14, 14.24, 14.37, 14.49, 14.50)

MRE11A
MRE11 meiotic recombination 11 homolog A



11q21
* ataxia telangiectasia-like disorder - ATLD (13.64)

MRPL3
Mitochondrial ribosomal protein L3(M)



3q21-q23
* Hypertrophic mitochondrial cardiomyopathy related to MRPL3 - (10.26)

MRPL44
Mitochondrial ribosomal protein L44(M)



2q36.1
* Mitochondrial hypertrophic cardiomyopathy related to MRPL44 - COXPD16 (10.29)

MSTN
Myostatin



2q32.2
* Muscle hypertrophy - MSLHP (5.18)

MTM1
Myotubularin



Xq28
* Myotubular myopathy, X-linked - MTM1 (3.16)

MTMR2
Myotubularin-related protein 2



11q22
* Charcot-Marie-Tooth disease, type 4B1 - CMT4B1 (14.18)

MTO1
Mitochondrial tRNA translation optimization 1(M)



6q13
* Mitochondrial hypertrophic cardiomyopathy related to MTO1 - COXPD10 (10.28)

MTPAP
mitochondrial poly(A) polymerase(M)



10p12.1
* Spastic ataxia 4 autosomal recessive - SPAX4 (15.70)

MURC
Muscle-related coiled-coil protein



9q31.1
* Dilated cardiomyopathy related to MURC - (10.68)

MUSK
muscle, skeletal, receptor tyrosine kinase



9q31.3-q32
* Congenital myasthenic syndrome related to MuSK - CMS1B (11.14)

MYBPC3
Cardiac myosin binding protein-C



11p11.2
* Cardimyopathy, dilated, 1A - CMD1A (3.41, 10.4, 10.55)
* Dilated cardiomyopathy related to MYBPC3 - (3.41, 10.4, 10.55)
* congenital skeletal myopathy and fatal cardiomyopathy - (3.41, 10.4, 10.55)
* Cardiomyopathy, familial hypertrophic, 4 - CMH4 (3.41, 10.4, 10.55)

MYH2
Myosin, heavy polypeptide 2, skeletal muscle



17p13.1
* Myopathy proximal to ophthalmoplegia, recessive (Inclusion body myopathy 3) - MYPOP (3.32, 3.33, 3.34)
* Myopathy with joint contractures, ophtalmoplegia, and rimmed vacuoles - IBM3 (3.32, 3.33, 3.34)

MYH3
Myosine, heavy chain 3, skeletal muscle, embryonic



17p13
* Arthrogryposis, distal, type 2A - DA2A (16.9, 16.12)
* Arthrogryposis, distal, type 2B - DA2B (16.9, 16.12)

MYH6
Myosin heavy chain 6



14q12
* Cardiomyopathy, dilated, 1EE - CMD1EE (10.1, 10.13, 10.65)
* Familial hypertrophic cardiomyopathy, 14 - CMH14 (10.1, 10.13, 10.65)
* Cardiomyopathy, familial hypertrophic 1 - CMH1 (10.1, 10.13, 10.65)

MYH7
Myosin, heavy polypeptide 7, cardiac muscle, beta



14q12
* Cardiomyopathy, dilated, 1S - CMD1S (3.15, 3.30, 3.31, 4.4, 10.1, 10.48)
* myopathy, congenital, with fiber-type disproportion - CFTD (3.15, 3.30, 3.31, 4.4, 10.1, 10.48)
* Myopathy, distal 1 - MPD1 (3.15, 3.30, 3.31, 4.4, 10.1, 10.48)
* cardiomyopathy, familial hypertrophic, 1, included - CMH1 (3.15, 3.30, 3.31, 4.4, 10.1, 10.48)
* Myosin storage myopathy - (3.15, 3.30, 3.31, 4.4, 10.1, 10.48)

MYH8
Myosin heavy chain, 8, skeletal muscle, perinatal



17p13
* Myosin, heavy chain, perinatal - MYH8 (16.15)

MYL2
Myosin light chain 2



12q23-q24.3
* Cardiomyopathy, familial hypertrophic, 10 - CMH10 (10.9)
* Cardiomyopathy, hypertrophic, mid-left ventricular chamber type - MYL2 (10.9)

MYL3
Myosin light chain 3



3p21.3-p21.2
* Cardiomopathy, hypertrophic, mid-ventricular chamber type - MYL3 (10.7)

MYLK2
Myosin light chain kinase 2



20q13.31
* cardiomyopathy, familial hypertrophic - CMH (10.15)

MYO9A
myosin IXA



15q23
* Congenital Myasthenia - (11.31)

MYOT
Myotilin



5q31
* Myofibrillar myopathy, myotilin related - MFM3 (1.13, 4.9, 5.6, 5.7)
* Spheroid body myopathy - (1.13, 4.9, 5.6, 5.7)
* Muscular dystrophy, Limb-Girdle, type 1A - LGMD1A (1.13, 4.9, 5.6, 5.7)

MYOZ2
Myozenin 2, or calsarcin 1, a Z disk protein



4q26
* Hypertrophic cardiomyopathy related to myozenin 2 - (10.17)
* Cardiomyopathy, familial hypertrophic, 16 - CMH16 - CMH16 (10.17)

MYPN
Myopalladin



10q21.1
* Dilated cardiomyopathy related to myopalladin - (10.61)